CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-02 | Parrish Jay Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −2,315 | 48,611 | ||
| 2020-10-27 | Virgin Herbert EVP, Research & CSO | Option exercise | +3,805 | $1.53 | $6K | 27,505 |
| 2020-10-27 | Virgin Herbert EVP, Research & CSO | Sale | −3,805 | $35.04 | $133K | 23,700 |
| 2020-10-27 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −3,805 | 450,510 | ||
| 2020-10-21 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $31.44 | $157K | 29,777 |
| 2020-10-21 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −5,000 | 87,591 | ||
| 2020-10-21 | Pang Phillip Chief Medical Officer | Option exercise | +7,870 | $1.53 | $12K | 37,647 |
| 2020-10-21 | Pang Phillip Chief Medical Officer | Option exercise | +2,315 | $1.58 | $4K | 39,962 |
| 2020-10-21 | Pang Phillip Chief Medical Officer | Option exercise | +2,315 | $5.18 | $12K | 42,277 |
| 2020-10-21 | Pang Phillip Chief Medical Officer | Sale | −7,500 | $35.42 | $266K | 34,777 |
| 2020-10-21 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $35.59 | $178K | 29,777 |
| 2020-10-21 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −7,870 | 92,591 | ||
| 2020-10-21 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −2,315 | 48,612 | ||
| 2020-10-21 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −2,315 | 67,129 | ||
| 2020-10-13 | Virgin Herbert EVP, Research & CSO | Option exercise | +5,560 | $1.53 | $9K | 29,260 |
| 2020-10-13 | Virgin Herbert EVP, Research & CSO | Sale | −5,560 | $43.03 | $239K | 23,700 |
| 2020-10-13 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −5,560 | 454,315 | ||
| 2020-10-07 | Pang Phillip Chief Medical Officer | Option exercise | +10,185 | $1.53 | $16K | 39,962 |
| 2020-10-07 | Pang Phillip Chief Medical Officer | Option exercise | +2,315 | $1.58 | $4K | 42,277 |
| 2020-10-07 | Pang Phillip Chief Medical Officer | Sale | −7,500 | $41.76 | $313K | 34,777 |
Page 49 of 54 · 1,063 trades